REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-12-17: Form 6-K; Period of report 2019-12-17; Description FORM 6-K; Document f6k_121719.htm.
- 2019-11-21: Form 6-K; Period of report 2019-11-21; Description FORM 6-K; Document f6k_112119.htm.
- 2019-11-20: Form 6-K; Period of report 2019-11-20; Description FORM 6-K; Document f6k_112019.htm.
- 2019-11-19: Form 6-K; Period of report 2019-11-19; Description FORM 6-K; Document f6k_111919.htm.